Toggle navigation
Home
Market Overview
About
Tweet #OpraMe
Cadence Pharmaceuticals, Inc. (CADX) Options Report
Last Sale:
2.80
Market Value:
239.16M
IPO Year:
1985
Sector:
Consumer Durables
Industry:
Major Pharmaceuticals
As of Date:
Dec 1, 2011
Price distribution
Correlation